Article
Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling
2023-03-20
Abstract excerpt
Minimally invasive technologies for early diagnosis of epithelial ovarian cancer (EOC) remain an unmet clinical need. CA-125, a tumor marker secreted into the circulation, is utilized to monitor treatment response and disease relapse in EOC, but has limited utility in accurately triaging patients with pelvic masses of unknown histology. To address this unmet need, we applied a novel blood-based glycoproteomic plat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 346e2134-fb64-5fea-88d3-2aab5462a86c
- DOI
- 10.1101/2023.03.20.23287422
